A randomized phase II trial of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) plus prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC).
Meeting Abstract
Small, Eric Jay; Lance, Raymond S.; Redfern, Charles H.; Millard, Frederick E.; Gardner, Thomas A.; Karsh, Lawrence Ivan; Dawson, Nancy Ann; McCoy, Candice; Stubbs, Andrew; DeVries, Todd; dela Rosa, Corazon P.; Sheikh, Nadeem A.; Shore, Neal D.